These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16838558)

  • 1. [Fever in the neutropenic onco-hematologic patient: critical considerations].
    Garavelli PL
    Recenti Prog Med; 2006 May; 97(5):266. PubMed ID: 16838558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infection therapy in neutropenia].
    Adam D
    Dtsch Med Wochenschr; 1999 Apr; 124 Suppl 1():S2. PubMed ID: 10410647
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
    Bodey GP
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i3-13. PubMed ID: 19372179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
    Pizzo PA
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i16-7. PubMed ID: 19372174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial therapy in neutropenia].
    Maschmeyer G; Vogt K; Hahn H; Dörken B
    Dtsch Med Wochenschr; 1997 Jul; 122(27):864-9. PubMed ID: 9280698
    [No Abstract]   [Full Text] [Related]  

  • 6. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hidden sepsis marker: aPTT waveform analysis.
    Dempfle CE; Borggrefe M
    Thromb Haemost; 2008 Jul; 100(1):9-10. PubMed ID: 18612529
    [No Abstract]   [Full Text] [Related]  

  • 8. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
    Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
    [No Abstract]   [Full Text] [Related]  

  • 9. Outpatient antibiotic therapy in febrile neutropenic patients undergoing high-dose chemotherapy and autologous bone marrow support.
    Rubenstein EB; Rolston K; Elting L
    J Clin Oncol; 1994 Nov; 12(11):2516-7. PubMed ID: 7964970
    [No Abstract]   [Full Text] [Related]  

  • 10. Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy.
    de Pauw BE; Rubin RH
    Transpl Infect Dis; 2006 Mar; 8(1):1-2. PubMed ID: 16623814
    [No Abstract]   [Full Text] [Related]  

  • 11. The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia.
    Tromp YH; Daenen SM; Sluiter WJ; Vellenga E
    Eur J Cancer; 2009 Mar; 45(4):596-600. PubMed ID: 19095436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The irreplaceable image: Nails changes in onco-hematologic patients.
    Vassallo C; Brazzelli V; Ardigò M; Borroni G
    Haematologica; 2001 Mar; 86(3):334-6. PubMed ID: 11255290
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.
    Nakamura A; Sugimoto Y; Ohishi K; Sugawara Y; Fujieda A; Monma F; Suzuki K; Masuya M; Nakase K; Matsushima Y; Wada H; Katayama N; Nobori T
    J Clin Microbiol; 2010 Jun; 48(6):2030-6. PubMed ID: 20392911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of infections during intensive treatment of hematologic malignancies.
    Maschmeyer G; Hiddemann W; Link H; Cornely OA; Buchheidt D; Glass B; Adam D
    Ann Hematol; 1997; 75(1-2):9-16. PubMed ID: 9322678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment at home, a wonderful prospect].
    Letonturier P
    Presse Med; 2004 Apr; 33(7):459. PubMed ID: 15105767
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria parasitemia associated with febrile neutropenia in African patients undergoing chemotherapy for haematological malignancies. A report of three patients.
    Rapoport BL; Uys A
    Chemotherapy; 2008; 54(2):117-9. PubMed ID: 18303260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cordonnier C
    Haematologica; 2006 Feb; 91(2):150a. PubMed ID: 16461296
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why monotherapy?
    Williams KJ
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i18-20. PubMed ID: 19372175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low impact of urine cultures as a diagnostic tool in patients with neutropenic fever.
    Steinrücken J; Pabst T; Zimmerli S; Marschall J
    Infect Dis (Lond); 2016; 48(11-12):872-4. PubMed ID: 27387039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.